← All trials
NCT05299567
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 24, 2010
- Primary completion
- Jul 21, 2011
- Completion date
- Jul 21, 2011
- First posted
- Mar 29, 2022
- Last posted
- Mar 29, 2022
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hospital JP GarrahanLead sponsor
- Hospital JP GarrahanSponsor investigator
- Hospital de Pediatría Prof Dr. Juan P. GarrahanOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.